Comparative Effectiveness of Pharmacotherapies for Prevention of Atrial Fibrillation Following Coronary Artery Bypass Surgery
Jonathan P. Piccini(Clinical Research Institute), Eric D. Peterson(The University of Texas Southwestern Medical Center), Xia He(Kunming University of Science and Technology), Joseph P. Mathew(Duke University), Adrian F. Hernandez(Duke University), David A. Fullerton(University of Denver), Winslow Klaskala(Johnson & Johnson (United States)), Roger M. Mills(Janssen (Belgium)), Donald D. Hegland(Clinical Research Institute), Benjamin A. Steinberg(University of Utah), Yue Zhao(Tulane University)
Cited by 20
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k